Your browser doesn't support javascript.
loading
Vanucizumab mode of action: Serial biomarkers in plasma, tumor, and skin-wound-healing biopsies.
Heil, Florian; Babitzki, Galina; Julien-Laferriere, Alice; Ooi, Chia-Huey; Hidalgo, Manuel; Massard, Christophe; Martinez-Garcia, Maria; Le Tourneau, Christophe; Kockx, Mark; Gerber, Peter; Rossomanno, Simona; Krieter, Oliver; Lahr, Angelika; Wild, Norbert; Harring, Suzana Vega; Lechner, Katharina.
Afiliação
  • Heil F; Roche Innovation Center Munich, Nonnenwald 2, 82377 Penzberg, Germany. Electronic address: florian.heil@roche.com.
  • Babitzki G; Roche Innovation Center Munich, Nonnenwald 2, 82377 Penzberg, Germany. Electronic address: galina.babitzki@roche.com.
  • Julien-Laferriere A; Soladis GmbH, Basel, Switzerland. Electronic address: alice.julien-laferriere@roche.com.
  • Ooi CH; Roche Innovation Center Basel, Basel, Switzerland. Electronic address: chia-huey.ooi@roche.com.
  • Hidalgo M; Division of Hematology and Medical Oncology, Weill Cornell Medicine and New York-Presbyterian Hospital, New York, USA. Electronic address: mhidalgo@bidmc.harvard.edu.
  • Massard C; Institut Gustave Roussy, DITEP, Villejuif, France. Electronic address: Christophe.MASSARD@gustaveroussy.fr.
  • Martinez-Garcia M; Hospital del Mar, Oncologia Medica, Barcelona, Spain. Electronic address: MariaMartinezGarcia@parcdesalutmar.cat.
  • Le Tourneau C; Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France; INSERM U900 Research unit, Institut Curie, Saint-Cloud, France; Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. Electronic address: christophe.letourneau@curie.fr.
  • Kockx M; HistoGeneX N.V., Wilrijk, Belgium. Electronic address: mark.kockx@histogenex.com.
  • Gerber P; Roche Innovation Center Basel, Basel, Switzerland. Electronic address: p.gerber1@gmx.de.
  • Rossomanno S; Roche Innovation Center Basel, Basel, Switzerland. Electronic address: simona.rossomanno@roche.com.
  • Krieter O; Roche Innovation Center Munich, Nonnenwald 2, 82377 Penzberg, Germany. Electronic address: oliver.krieter@roche.com.
  • Lahr A; Roche Innovation Center Munich, Nonnenwald 2, 82377 Penzberg, Germany. Electronic address: angelika.lahr@roche.com.
  • Wild N; Roche Centralized and Point of Care Solutions, Penzberg, Germany. Electronic address: norbert.wild@roche.com.
  • Harring SV; Roche Innovation Center Munich, Nonnenwald 2, 82377 Penzberg, Germany. Electronic address: suzana.vega_harring@roche.com.
  • Lechner K; Roche Innovation Center Munich, Nonnenwald 2, 82377 Penzberg, Germany. Electronic address: katharina.lechner@roche.com.
Transl Oncol ; 14(2): 100984, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33338877

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article